4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-037106
Director sold 4,500 shares at $24.87 ($111,906)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brege Laura Director | 2023-06-12 | Sale 10b5-1 | −4,500 | $24.87 | $111,906 | 13,502 | D |
| Open-market sales · 4,500 sh · avg $24.87 · $111,906 | |||||||
Loading xslF345X04/doc4.xml…